GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,709.40p
   
  • Change Today:
      4.20p
  • 52 Week High: 1,711.20
  • 52 Week Low: 1,316.00
  • Currency: UK Pounds
  • Shares Issued: 4,144.88m
  • Volume: 1,657,904
  • Market Cap: £70,853m
  • RiskGrade: 129

Regulatory News

Director/PDMR Shareholding 26-Mar-2024 15:30 RNS
Notice of AGM 25-Mar-2024 13:00 RNS
Transfer of Treasury Shares 22-Mar-2024 16:20 RNS
Director/PDMR Shareholding 22-Mar-2024 15:36 RNS
New Phase III Jemperli data in endometrial cancer 18-Mar-2024 09:30 RNS
Director/PDMR Shareholding 13-Mar-2024 15:48 RNS
Board Committee Change 08-Mar-2024 17:12 RNS
GSK announces positive Blenrep DREAMM-8 results 07-Mar-2024 07:00 RNS
ViiV LAI vs oral SOC data in adherence-challenged 06-Mar-2024 16:00 RNS
GSK Annual Report 2023 on Form 20-F 05-Mar-2024 17:24 RNS
New ViiV LA formulation potential 4-month dosing 05-Mar-2024 07:00 RNS
Total Voting Rights 01-Mar-2024 15:00 RNS
GSK publishes Annual Report 2023 01-Mar-2024 12:15 RNS
Directorate Change 29-Feb-2024 07:05 RNS
Statement: Zantac (ranitidine) litigation 29-Feb-2024 07:00 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,709.40p
Change Today 4.20p
% Change 0.25 %
52 Week High 1,711.20
52 Week Low 1,316.00
Volume 1,657,904
Shares Issued 4,144.88m
Market Cap £70,853m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
83.02% below the market average83.02% below the market average83.02% below the market average83.02% below the market average83.02% below the market average
51.85% below the sector average51.85% below the sector average51.85% below the sector average51.85% below the sector average51.85% below the sector average
Price Trend
49.26% above the market average49.26% above the market average49.26% above the market average49.26% above the market average49.26% above the market average
75.44% above the sector average75.44% above the sector average75.44% above the sector average75.44% above the sector average75.44% above the sector average
Income
35.10% above the market average35.10% above the market average35.10% above the market average35.10% above the market average35.10% above the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
Growth
27.09% below the market average27.09% below the market average27.09% below the market average27.09% below the market average27.09% below the market average
29.73% above the sector average29.73% above the sector average29.73% above the sector average29.73% above the sector average29.73% above the sector average

What The Brokers Say

Strong Buy 7
Buy 6
Neutral 9
Sell 2
Strong Sell 0
Total 24
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q4 Q3
Ex-Div 22-Feb-24 16-Nov-23
Paid 11-Apr-24 11-Jan-24
Amount 16.00p 14.00p

Trades for 28-Mar-2024

Time Volume / Share Price
14:59 755 @ 1,709.60p
14:59 46 @ 1,709.40p
14:59 183 @ 1,709.40p
14:59 173 @ 1,709.40p
14:58 26 @ 1,709.40p

GSK Key Personnel

CEO Emma Walmsley

Top of Page